Background High serum levels of interleukin 6 (IL-6) predict poor prognosis in intrahepatic cholangiocarcinoma (iCCA), a malignancy that often develops in a chronically inflamed milieu . Here, tumour ...

A new class of weight loss drug just took a major step toward approval for use. In a phase III clinical trial, medication ...

DURHAM, N.C., March 17, 2026 - MedPharm, a global leader in topical and transdermal contract drug development and manufacturing, today welcomed the news that its partner, Palvella Therapeutics, Inc. ( ...

Patent strengthens global intellectual property protection for QTORIN rapamycin, Palvella's lead product candidate from the QTORIN platform, in development for serious, rare skin diseases and vascular ...

Patent strengthens global intellectual property protection for QTORIN™ rapamycin, Palvella’s lead product candidate from the ...

Global breast cancer incidence continues to rise and researchers have reported that nanoformulations of curcumin may overcome longstanding bioavailability barriers to enhance antitumour efficacy, ...

The biological mystery of how many mammals transitioned from being nocturnal to active in the daytime following the extinction of the dinosaurs has been cracked by researchers in Cambridge. The study, ...

New corporate identity reflects the Company’s mission to develop novel medicines to modulate filamin A and address unmet needs in treating TSC-related epilepsy ...

BEYONDmLM.comcampaign designed to educate, engage, and empower patients, caregivers, and healthcare professionalsCampaign developed and launched ...

Detailed price information for Palvella Therapeutics Inc (PVLA-Q) from The Globe and Mail including charting and trades.

As previously presented, gedatolisib + palbociclib + fulvestrant ('gedatolisib triplet”) and gedatolisib + fulvestrant ('gedatolisib doublet”) reduced the risk of disease progression or death versus ...

Scientists reprogrammed two widely used “chemically induced proximity” systems in a recent chemical science paper. CIP systems are very simple: when a small molecule is added, two engineered protein ...